Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine vs Placebo on Hepatic Insulin Extraction
NCT02447835Phase 1Completed
- Start
- Aug 2012
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial in schizophrenia comparing Olanzapine with Placebo (2 arms). Primary endpoint: Vagal contribution to the olanzapine-induced increase in circulating insulin levels at 12 days. Started Aug 2012; status: completed.
02
Drugs
olanzapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT02447835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02447835.